Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group).
Fiona L DaySwetha SridharanJames LynamCraig GedyeCatherine JohnsonAllison FraserStephen R ThompsonMichael MichaelTrevor LeongAmitesh RoyMahesh KumarAndre van der WesthuizenGaik T QuahHiren MandaliyaGirish MallesaraJoshua SappiatzerChristopher OldmeadowJarad MartinPublished in: BMC cancer (2022)
Australian and New Zealand Clinical Trials Registry: ACTRN12619001371189 , registered 8 October 2019.